Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Lipid Signaling and Metabolism provides foundational knowledge and methods to examine lipid metabolism and bioactive lipid signaling mediators that regulate a broad spectrum of biological processes and disease states. Here, world-renowned investigators offer a basic examination of general lipid, metabolism, intracellular lipid storage and utilization that is followed by an in-depth discussion of lipid signaling and metabolism across disease areas, including obesity, diabetes, fatty liver disease, inflammation, cancer, cardiovascular disease and mood-related disorders. Throughout, authors demonstrate how expanding our understanding of lipid mediators in metabolism and signaling enables opportunities for novel therapeutics.
Emphasis is placed on bioactive lipid metabolism and research that has been impacted by new technologies and their new potential to transform precision medicine.
- Provides a clear, up-to-date understanding of lipid signaling and metabolism and the impact of recent technologies critical to advancing new studies
- Empowers researchers to examine bioactive lipid signaling and metabolism, supporting translation to clinical care and precision medicine
- Discusses the role of lipid signaling and metabolism in obesity, diabetes, fatty liver disease, inflammation, cancer, cardiovascular disease and mood-related disorders, among others
Active researchers in biochemistry, molecular biology, nutrition, endocrinology, cell biology, gastroenterology, and pharmacology; clinician scientists
1. Homeostatic Control of Membrane Lipid Biosynthesis in Bacteria
Diego de Mendoza
2. Lipid trafficking and signaling in plants
3. Sex as a modulator of lipid metabolism and metabolic disease
4. Local interactions in the bone marrow microenvironment and their contribution to system metabolic processes
5. Lipids in the Transcriptional Regulation of Adipocyte Differentiation and Metabolism
6. Lipid receptors and signaling in adipose tissue
7. Adipocyte lipolysis and lipid derived metabolite signaling
8. Regulation of Intracellular Lipid Storage and Utilization
9. The lipid droplet as a signaling node
Doug Gene Mashek
10. Lipid droplets in the immune response and beyond
11. Fatty acids mediators and the inflammasome
12. Identification and pathophysiological roles of LTB4 receptors BLT1 and BLT2
13. The Forkhead Box O family in Insulin Action and Lipid Metabolism
H. Henry Dong
14. Interplays between nutritional and inflammatory signaling and fat metabolism in pathophysiology of NAFLD
15. Endocannabinoids: The Lipid Effectors of Metabolic Regulation in Health and Disease
16. Gut Microbiota Interaction in Host Lipid Metabolism
Matam Vijay-Kumar (Vijay)
17. Insights into the metabolism of lipids in Obesity and Diabetes
Emmanuel Mukwevho and James M. Ntambi
18. Lipid metabolic features of skeletal muscle in pathological and physiological conditions
Chad M. Paton
19. Sphingolipid mediators of cell signaling and metabolism
20. Role of bile acid receptors in the regulation of cardiovascular diseases
21. Molecular Mechanisms Underlying Effects of n-3 and n-6 Fatty Acids in Cardiovascular Diseases
Richard J. Deckelbaum
22. Lipid metabolism and signaling in Cancer
23. Altered lipid metabolic homeostasis in Alzheimer’s disease
24. Role of Xenosterols in Health and Disease
Babunageswararao Kanuri and Shailendra Patel
25. Adipose Tissue Development and Metabolic Regulation
Hei Sook Sul
- No. of pages:
- © Academic Press 2020
- 1st August 2020
- Academic Press
- Paperback ISBN:
Dr. James M. Ntambi is Professor of Biochemistry and the Steenbock Professor of Nutritional Sciences, at the University of Wisconsin-Madison, as well as Adjunct Professor of Biological Chemistry at Johns Hopkins University School of Medicine. The focus of Dr. Ntambi's research is to understand the genetic regulation of metabolism, adipocyte biology, and differentiation. He is specifically interested in the genetic basis of obesity, cardiovascular disease, insulin resistance, diabetes and fatty live disease and how dietary factors, hormones, and environmental factors influence these disease states. Most recently, his team have genetically engineered mice that are born without the stearoyl-CoA desaturase gene-1, and found that these mice resist obesity, diabetes, and fatty liver disease. Dr. Ntambi also conducts research on obesity and diabetes and other non-communicable metabolic diseases in developing countries. He has set up the Lweza-Mukono Community Health Initiatives Inc. (lwezahealth.org) a registered organization operating as a center of excellence in Lweza village Mukono District, Uganda implementing projects linking health to agriculture, nutrition and education to address, prevent, delay and manage the non-communicable metabolic diseases referred to above. Dr. Ntambi has published more than 200 scientific articles in such journals as Cell Metabolism, JBC, Journal of Lipid research, PNAS, JCI, Scientific Reports, PLoS ONE, BBRC, Gastroenterology, and Journal of Hepatology.
Professor of Biochemistry, Steenbock Professor of Nutritional Sciences, University of Wisconsin-Madison, Madison, WI, USA
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.